Beranda300601 • SHE
add
Shenzhen Kangtai Biological Prods Co Ltd
Tutup sebelumnya
¥13,91
Rentang hari
¥13,86 - ¥14,13
Rentang tahun
¥12,93 - ¥23,45
Kapitalisasi pasar
15,54 M CNY
Volume Rata-Rata
12,20 jt
Rasio P/E
103,43
Hasil dividen
-
Bursa utama
SHE
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (CNY) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 645,20 jt | 42,85% |
Biaya operasional | 424,14 jt | 38,76% |
Laba bersih | 22,43 jt | -58,51% |
Margin laba bersih | 3,48 | -70,93% |
Penghasilan per saham | — | — |
EBITDA | 127,47 jt | 2,48% |
Tarif pajak efektif | 17,00% | — |
Neraca
Total aset
Total liabilitas
| (CNY) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 219,94 jt | -77,94% |
Total aset | 14,25 M | -5,10% |
Total liabilitas | 4,57 M | -15,33% |
Total ekuitas | 9,68 M | — |
Saham yang beredar | 1,12 M | — |
Harga terhadap nilai buku | 1,60 | — |
Tingkat pengembalian aset | 0,86% | — |
Tingkat pengembalian modal | 1,07% | — |
Arus Kas
Perubahan kas bersih
| (CNY) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 22,43 jt | -58,51% |
Kas dari operasi | -46,30 jt | 39,22% |
Kas dari investasi | -65,23 jt | 82,73% |
Kas dari pembiayaan | -98,94 jt | -180,59% |
Perubahan kas bersih | -210,53 jt | 36,40% |
Arus kas bebas | -2,72 M | -245,41% |
Tentang
Shenzhen Kangtai Biological Products, also known as BioKangtai, is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products.
Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China. Wikipedia
Didirikan
8 Sep 1992
Situs
Karyawan
1.913
